About the company
Minapharm Pharmaceuticals
Pharmaceutical Manufacturing, Manufacturing, and Biotechnology Research
About Minapharm
Minapharm Pharmaceuticals is a leading pharmaceutical company in Egypt and the Middle East and the largest end-to-end manufacturer of biological therapies in MEA with over 20 years of experience in cellular and bioprocess engineering.
Headquartered in Cairo, Minapharm commercializes over 100 life-saving and life-enhancing products ranging from small molecules to complex bioengineered proteins and viral vectors, with an impressive immunotherapy pipeline.
Together with its wholly-owned Berlin-based subsidiary, ProBioGen AG - a world-leading CDMO, Minapharm has established an integrated business model making it the only gene-to-market company in the region.
Consolidating its international platform of intelligent biopharmaceutical technologies with the longstanding process development and manufacturing expertise in the MEA, Minapharm, together with ProBioGen, has incorporated MiGenTra GmbH headquartered in Berlin and manufacturing in Cairo, to enhance the accessibility to critical healthcare transforming medicines through product development and commercialization of Biosimilar mABs, Cell, and Gene Therapies and vaccines, at affordable prices in Egypt, and MEA.
Minapharm employs a collective workforce of over than 1400 individuals & continues to expand their workforce with talented pool of Human Capital.
Our Core Values:
Job Summary:
Deliver the recurring planning, forecasting and performance analysis cycle for Minapharm and its subsidiaries, and provide the analytical support behind management and board reporting. The role is expected to make active and disciplined use of AI tools to accelerate analysis, modelling and reporting output.
Requirements:
Responsibilities:
Planning & Forecasting
Performance Analysis & Reporting
Board Reporting
Business Partnering
Support in reconciling management reporting to statutory results with Group Reporting